SHZ · Financial Statements

Shanghai Kehua Bio-Engineering Co.,Ltd (002022.SZ) Financial Statements

$5.70 SHZ: 002022.SZ Market Cap $2.91B

Full income statement, balance sheet, and cash flow statement for Shanghai Kehua Bio-Engineering Co.,Ltd (002022.SZ), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio3.23
EV / EBITDA-7.37
FCF Yield—
Quick Ratio1.17
Interest Coverage—
Return 1Y-11.76%
Return 3Y-31.90%
Return 5Y-56.12%

Shanghai Kehua Bio-Engineering Co.,Ltd (002022.SZ) financials — frequently asked questions

What is 002022.SZ EV/EBITDA?

Shanghai Kehua Bio-Engineering Co.,Ltd's enterprise value to EBITDA (EV/EBITDA) ratio is -7.37. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
002022.SZ Overview 002022.SZ Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.